Your browser doesn't support javascript.
loading
In Vitro and in Silico Studies of Potential Coronavirus-Specific 3C-Like Protease Inhibitors.
Maehara, Shoji; Kobayashi, Manami; Kuwada, Mari; Choshi, Tominari; Inoue, Hirofumi; Hieda, Yuhzou; Nishiyama, Takashi; Hata, Toshiyuki.
Affiliation
  • Maehara S; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.
  • Kobayashi M; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.
  • Kuwada M; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.
  • Choshi T; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.
  • Inoue H; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.
  • Hieda Y; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.
  • Nishiyama T; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.
  • Hata T; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.
Chem Pharm Bull (Tokyo) ; 70(3): 195-198, 2022 Mar 01.
Article in En | MEDLINE | ID: mdl-34955489

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Chem Pharm Bull (Tokyo) Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Chem Pharm Bull (Tokyo) Year: 2022 Document type: Article